(Tromsø 16. January 2018) ArcticZymes has achieved its first ISO13485 accreditation while Biotec BetaGlucan’s renews its longstanding ISO13485 accreditation follow recent review and approval.
Achieving ISO13485 certification is a key milestone for ArcticZymes in elevating its quality standard. This will become increasingly important as the regulatory authorities tighten up regulations on diagnostic companies and their suppliers over the next few years. By receiving ISO13485, ArcticZymes has readied itself in securing its operational freedom to continue serving In Vitro Diagnostic (IVD) customers. Biotec BetaGlucans was once again received approval according to ISO13485, confirming the high standards the Company needs to conform to as part of its regular business operations.
For more information, please contact: